CDX2 in colorectal cancer is an independent prognostic factor and regulated by promoter methylation and histone deacetylation in tumors of the serrated pathway

Janina Graule, Kristin Uth, Elia Fischer, Irene Centeno, José A. Galván, Micha Eichmann, Tilman T. Rau, Rupert Langer, Heather Dawson, Ulrich Nitsche, Peter Traeger, Martin D. Berger, Beat Schnüriger, Marion Hädrich, Peter Studer, Daniel Inderbitzin, Alessandro Lugli, Mario P. Tschan, Inti Zlobec

Open source

DOI: 10.1186/s13148-018-0548-2
Published: 2018-09-26
Container: Clinical Epigenetics
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1186/s13148-018-0548-2,
  title = {CDX2 in colorectal cancer is an independent prognostic factor and regulated by promoter methylation and histone deacetylation in tumors of the serrated pathway},
  author = {Janina Graule and Kristin Uth and Elia Fischer and Irene Centeno and José A. Galván and Micha Eichmann and Tilman T. Rau and Rupert Langer and Heather Dawson and Ulrich Nitsche and Peter Traeger and Martin D. Berger and Beat Schnüriger and Marion Hädrich and Peter Studer and Daniel Inderbitzin and Alessandro Lugli and Mario P. Tschan and Inti Zlobec},
  year = {2018},
  journal = {Clinical Epigenetics},
  doi = {10.1186/s13148-018-0548-2},
  url = {https://doi.org/10.1186/s13148-018-0548-2}
}

RIS

TY  - JOUR
TI  - CDX2 in colorectal cancer is an independent prognostic factor and regulated by promoter methylation and histone deacetylation in tumors of the serrated pathway
AU  - Janina Graule
AU  - Kristin Uth
AU  - Elia Fischer
AU  - Irene Centeno
AU  - José A. Galván
AU  - Micha Eichmann
AU  - Tilman T. Rau
AU  - Rupert Langer
AU  - Heather Dawson
AU  - Ulrich Nitsche
AU  - Peter Traeger
AU  - Martin D. Berger
AU  - Beat Schnüriger
AU  - Marion Hädrich
AU  - Peter Studer
AU  - Daniel Inderbitzin
AU  - Alessandro Lugli
AU  - Mario P. Tschan
AU  - Inti Zlobec
PY  - 2018
JO  - Clinical Epigenetics
DO  - 10.1186/s13148-018-0548-2
UR  - https://doi.org/10.1186/s13148-018-0548-2
ER  -

APA

Graule, J., Uth, K., Fischer, E., Centeno, I., Galván, J. A., Eichmann, M., Rau, T. T., Langer, R., Dawson, H., Nitsche, U., Traeger, P., Berger, M. D., Schnüriger, B., Hädrich, M., Studer, P., Inderbitzin, D., Lugli, A., Tschan, M. P., & Zlobec, I. (2018). CDX2 in colorectal cancer is an independent prognostic factor and regulated by promoter methylation and histone deacetylation in tumors of the serrated pathway. Clinical Epigenetics. https://doi.org/10.1186/s13148-018-0548-2

Source records

crossref · retrieved 2026-09-25T12:00:09.763Z